StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories key Emerging Markets (India, China, Brazil, Russia, Colombia, Mexico, Vietnam) — Organic / Comparable Sales Growth (%) (%)

Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A

QuarterlyAnnual
Latest, Q3 2026
10.9%
Period ended Sep 30, 2026
Change on a year earlier
-0.2 pts
11.1% in Q3 2025
History
43 quarters
Since Q4 2015
Sources
43
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedKey Emerging Markets (India, China, Brazil, Russia, Colombia, Mexico, Vietnam) — Organic / Comparable Sales Growth (%) (%)Year on yearSource
Q3 2026Sep 30, 202610.9%-0.2 ptsSEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 202610.7%+2.0 ptsSEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 20269.4%+0.1 ptsSEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 20258.7%-0.1 ptsSEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 202511.1%+5.7 ptsSEC Filing (0001628280-25-045049) ↗
Q2 2025Jun 30, 20258.7%-0.1 ptsSEC Filing (0001628280-25-035135) ↗
Q1 2025Mar 31, 20259.3%-6.1 ptsSEC Filing (0001628280-25-017924) ↗
Q4 2024Dec 31, 20248.8%-2.6 ptsSEC Filing (0001628280-25-002092) ↗
Q3 2024Sep 30, 20245.4%-3.4 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2024Jun 30, 20248.8%-4.2 ptsSEC Filing (0001628280-24-032182) ↗
Q1 2024Mar 31, 202415.4%–SEC Filing (0001628280-24-016497) ↗
Q4 2023Dec 31, 202311.4%+1.1 ptsSEC Filing (0001628280-24-002009) ↗
Q3 2023Sep 30, 20238.8%-4.2 ptsSEC Filing (0001628280-23-034544) ↗
Q2 2023Jun 30, 202313.0%+5.9 ptsSEC Filing (0001628280-23-025156) ↗
Q4 2022Dec 31, 202210.3%+5.1 ptsSEC Filing (0001628280-23-001516) ↗
Q3 2022Sep 30, 202213.0%-4.9 ptsSEC Filing (0001628280-22-026588) ↗

Cite this data

StockData. (2026). Abbott Laboratories Key Emerging Markets (India, China, Brazil, Russia, Colombia, Mexico, Vietnam) — Organic / Comparable Sales Growth (%) (%), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/epd-kem-yoy-org

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.